A drug used to treat patients who suffer from diabetes may have the unexpected side effect of helping reduce early symptoms in persons who suffer from Parkinson’s disease.
Researchers at the University College London recently found that the drug exenatide, which the Food and Drug Administration (FDA) approved in 2005 for the treatment of diabetes, also may benefit persons with Parkinson’s disease. Researchers studied the effects of the drug on diabetic patients as compared to a control group that was on a placebo. They found that the diabetic patients who were on the drug showed better motor function after treatment. Patients on the drug showed reduced signs of decline, compared to those on the placebo.
The study only included a limited number of participants, and the researchers acknowledged that larger group samples may further confirm the findings of the study.